Clinical validated tool for the study of Age-Related Macular Degeneration
AMD RESEARCH
RETMARKER AI TECHNOLOGY MONITORS AND PREVENTS RETINAL DISEASES' COMPLICATIONS
AMD Research is used for the assisted grading of fundus images from AMD patients.
FAST LESION ANNOTATION
Developed for an Epidemiological Study, makes use of Retmarker’s image exploration features, adding very simple manual and preset annotation of Drusen (including confluence), Hypopigmentation, Hyperpigmentation, Geographic Atrophy and Exudative Lesions.
Play Video
RetmarkerAMD is a reliable and consistent semiautomated grading tool for AMD.
RetmarkerAMD validation may prompt its use both in clinical studies and in clinical trials.
Marques, J.P., Pires, J., Simão, J. et al. Validation of RetmarkerAMD as a semiautomatic grading software for AMD.
Nature: Eye (2019) External info
ACCURATE
LESIONS COUNT
Automated counting of lesions is a precise source of information, not prone to errors related to the complexity in the estimation of lesion areas present.
